
By genetically altering a patient’s T-cells to attack more than one site on cancer cells, researchers hope to devise better treatments. DENISE GRADY http://ift.tt/2hD92SW http://ift.tt/2zSSgdk The New York Times Health Immunotherapy, Leukemia November 20, 2017 at 12:00AM
Comments
Post a Comment